Phillip Pang Vir Biotechnology, Inc. (VIR) insider trading activity

Phillip Pang is EVP & Chief Medical Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 250,111 shares of VIR, which is worth approximately $1.68 Million. The most recent transaction as insider was on Dec 15, 2021, when has been sold 5,000 shares (Common Stock) at a price of $50.88 per share, resulting in proceeds of $254,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K

0% 3M change

0% 12M change

Total Value Held $1.68 Million

Phillip Pang Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2021	SELL Open market or private sale	$254,400 $50.88 p/Share	5,000 Reduced 5.11%	92,777 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 4.86%	97,777 Common Stock
Dec 01 2021	SELL Open market or private sale	$326,925 $43.59 p/Share	7,500 Reduced 7.48%	92,777 Common Stock
Nov 17 2021	SELL Open market or private sale	$181,400 $36.28 p/Share	5,000 Reduced 4.75%	100,277 Common Stock
Nov 17 2021	BUY Exercise of conversion of derivative security	$25,850 $5.17 p/Share	5,000 Added 4.53%	105,277 Common Stock
Nov 03 2021	SELL Open market or private sale	$182,350 $36.47 p/Share	5,000 Reduced 4.75%	100,277 Common Stock
Nov 03 2021	BUY Exercise of conversion of derivative security	$25,850 $5.17 p/Share	5,000 Added 4.53%	105,277 Common Stock
Oct 20 2021	SELL Open market or private sale	$158,600 $39.65 p/Share	4,000 Reduced 3.84%	100,277 Common Stock
Oct 06 2021	SELL Open market or private sale	$172,800 $34.56 p/Share	5,000 Reduced 4.58%	104,277 Common Stock
Sep 27 2021	BUY Exercise of conversion of derivative security	$4,300 $0.86 p/Share	5,000 Added 4.38%	109,277 Common Stock
Sep 15 2021	SELL Open market or private sale	$249,850 $49.97 p/Share	5,000 Reduced 4.58%	104,277 Common Stock
Sep 01 2021	SELL Open market or private sale	$247,600 $49.52 p/Share	5,000 Reduced 4.38%	109,277 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 4.19%	114,277 Common Stock
Aug 18 2021	SELL Open market or private sale	$211,150 $42.23 p/Share	5,000 Reduced 4.38%	109,277 Common Stock
Aug 18 2021	BUY Exercise of conversion of derivative security	$7,650 $1.53 p/Share	5,000 Added 4.19%	114,277 Common Stock
Aug 04 2021	SELL Open market or private sale	$174,600 $34.92 p/Share	5,000 Reduced 4.38%	109,277 Common Stock
Aug 04 2021	BUY Exercise of conversion of derivative security	$25,850 $5.17 p/Share	5,000 Added 4.19%	114,277 Common Stock
Jul 21 2021	SELL Open market or private sale	$173,347 $37.44 p/Share	4,630 Reduced 4.06%	109,277 Common Stock
Jul 21 2021	BUY Exercise of conversion of derivative security	$7,269 $1.57 p/Share	4,630 Added 3.91%	113,907 Common Stock
Jul 07 2021	SELL Open market or private sale	$202,700 $40.54 p/Share	5,000 Reduced 4.38%	109,277 Common Stock
Jul 07 2021	BUY Exercise of conversion of derivative security	$25,850 $5.17 p/Share	5,000 Added 4.19%	114,277 Common Stock
Jun 16 2021	SELL Open market or private sale	$218,350 $43.67 p/Share	5,000 Reduced 4.38%	109,277 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$25,850 $5.17 p/Share	5,000 Added 4.19%	114,277 Common Stock
Jun 02 2021	SELL Open market or private sale	$418,300 $41.83 p/Share	10,000 Reduced 8.38%	109,277 Common Stock
Jun 02 2021	BUY Exercise of conversion of derivative security	$8,600 $0.86 p/Share	10,000 Added 7.74%	119,277 Common Stock

Phillip Pang

EVP & Chief Medical Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Value

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR

Account